PAREXEL International Corporation  

(Public, NASDAQ:PRXL)   Watch this stock  
Find more results for Joseph Schneider
54.78
-0.11 (-0.20%)
After Hours: 55.21 +0.43 (0.78%)
Jul 30, 6:12PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 54.22 - 55.75
52 week 37.53 - 57.25
Open 55.32
Vol / Avg. 583,014.00/563,927.00
Mkt cap 3.12B
P/E 26.53
Div/yield     -
EPS 2.06
Shares 56.88M
Beta 0.92
Inst. own 100%
Aug 7, 2014
Q4 2014 PAREXEL International Corp Earnings Call - 10:00AM EDT - Add to calendar
Aug 6, 2014
Q4 2014 PAREXEL International Earnings Release - 4:00PM EDT - Add to calendar
Jun 25, 2014
PAREXEL International 2014 Investor Day - Webcast
Jun 18, 2014
PAREXEL International at Wells Fargo Healthcare Conference
Jun 10, 2014
PAREXEL International at Goldman Sachs Healthcare Conference - Webcast
Jun 4, 2014
PAREXEL International at Jefferies Global Healthcare Conference - Webcast
May 21, 2014
PAREXEL International at UBS Global Healthcare Conference - Webcast
May 13, 2014
PAREXEL International at Bank of America Merrill Lynch Health Care Conference - Webcast
May 7, 2014
PAREXEL International at Deutsche Bank Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 6.01% 4.81%
Operating margin 9.03% 6.82%
EBITD margin - 10.43%
Return on average assets 7.43% 5.80%
Return on average equity 21.46% 16.71%
Employees 14,700 -
CDP Score - -

Address

195 West Street
WALTHAM, MA 02451
United States - Map
+1-781-4879900 (Phone)
+1-781-4870525 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PAREXEL International Corporation (PAREXEL is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc. (Perceptive). The Company�s product and service offerings include clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics / outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, post-marketing surveillance, regulatory and product development and commercialization among others. In July 2014, PAREXEL International Corp acquired ATLAS Medical Services.

Officers and directors

Josef H. von Rickenbach Chairman of the Board, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Mark Goldberg President, Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Ingo Bank Chief Financial Officer, Senior Vice President
Age: 45
Bio & Compensation  - Reuters
Xavier Flinois President - Perceptive Informatics
Age: 51
Bio & Compensation  - Reuters
Joseph C. Avellone M.D. Executive Vice President
Bio & Compensation  - Reuters
James Francis Winschel Jr. Executive Vice President
Age: 64
Bio & Compensation  - Reuters
Ulf Schneider Ph.D. Chief Administrative Officer, Senior Vice President
Age: 56
Bio & Compensation  - Reuters
Douglas Alexander Batt Senior Vice President, General Counsel, Secretary
Age: 53
Bio & Compensation  - Reuters
Anita Cooper Ph.D. Senior Vice President, General Manager - Clinical Research Services
Age: 54
Bio & Compensation  - Reuters
Gadi Saarony Senior Vice President - Clinical Research Services
Age: 45
Bio & Compensation  - Reuters